首页|血浆长链非编码RNA浆细胞瘤变异易位基因1、微小RNA-143-3p表达水平与类风湿关节炎患者疾病活动度及预后的相关性分析

血浆长链非编码RNA浆细胞瘤变异易位基因1、微小RNA-143-3p表达水平与类风湿关节炎患者疾病活动度及预后的相关性分析

扫码查看
目的 分析血浆长链非编码RNA浆细胞瘤变异易位基因1(LncRNA PVT1)、微小RNA-143-3p(miR-143-3p)表达水平与类风湿关节炎(RA)患者疾病活动度及预后的相关性。方法 选取本院2021年4月—2023年4月收治的RA患者129例为疾病组,依据28个关节疾病活动度评分(DAS28)将患者分为疾病稳定组(n=28)、轻度活动组(n=42)、中度活动组(n=35)、重度活动组(n=24);根据治疗6个月的预后情况将其分为预后良好组(n=88)、预后不良组(n=41),另选取同期在本院体检的110例健康者为对照组。采用实时荧光定量聚合酶链式反应(qRT-PCR)检测血浆LncRNA PVT1、miR-143-3p表达水平;通过Target Scan Human网站预测LncRNA PVT1、miR-143-3p的靶向关系;采用多因素Logistic回归分析探讨RA患者预后的影响因素;绘制受试者工作特征(ROC)曲线分析血浆LncRNA PVTI、miR-143-3p对RA患者预后的预测价值。结果 疾病组血浆LncRNA PVT1水平高于对照组,血浆miR-143-3p水平低于对照组,差异有统计学意义(P<0。05)。重度活动组、中度活动组、轻度活动组、疾病稳定组血浆LncRNA PVT1水平依次降低,血浆miR-143-3p水平依次升高,差异有统计学意义(P<0。05)。预后不良组人类白细胞抗原-DR4(HLA-DR4)阳性占比、DAS28、血浆LncRNA PVT1表达水平高于预后良好组,血浆miR-143-3p水平低于预后良好组,差异有统计学意义(P<0。05)。血浆LncRNA PVTI、miR-143-3p表达、HLA-DR4阳性、DAS28为RA患者预后的影响因素(P<0。05)。LncRNA PVT1与miR-143-3p有靶向结合位点,且两者呈负相关(P<0。05)。血浆LncRNA PVT1与miR-143-3p联合预测RA患者预后的曲线下面积(AUC)为0。914,优于LncRNA PVT1、miR-143-3p单独诊断(Z=2。159,P=0。031;Z=2。108,P=0。035),联合诊断的敏感度、特异度分别为95。12%、78。41%。结论 血浆LncRNA PVT1水平随RA疾病活动度的增加而逐渐升高,而血浆miR-143-3p水平随疾病活动度的增加而逐渐降低,二者联合检测对RA患者预后有较高的预测价值。
Correlations of the expression levels of plasma long non-coding RNA plasmacytoma variant translocation 1 and microRNA-143-3p with disease activity and prognosis in patients with rheumatoid arthritis
Objective To investigate the correlations of the expression levels of plasma long non-coding RNA plasmacytoma variant translocation 1(LncRNA PVT1)and microRNA-143-3p(miR-143-3p)with disease activity and prognosis in patients with rheumatoid arthritis(RA).Meth-ods A total of 129 RA patients admitted to our hospital from April 2021 to April 2023 were selected as disease group.According to the 28-joint disease activity scores(DAS28),the patients were divid-ed into stable disease group(n=28),mildly active group(n=42),moderately active group(n=35),and severely active group(n=24).According to the prognosis of the patients after 6 months of treatment,they were divided into good prognosis group(n=88)and poor prognosis group(n=41),and 110 healthy people who underwent physical examinations in our hospital during the same period were included as control group.The expression levels of plasma LncRNA PVT1 and miR-143-3p were detected using quantitative real-time fluorescent polymerase chain reaction(qRT-PCR).The targeting relationship between LncRNA PVT1 and miR-143-3p was predicted using the Target Scan Human website.Multivariate Logistic regression analysis was conducted to explore the factors influ-encing the prognosis of RA patients.Receiver operating characteristic(ROC)curve was performed to assess the predictive value of plasma LncRNA PVT1 and miR-143-3p for the prognosis of RA pa-tients.Results The plasma LncRNA PVT1 level in the disease group was higher than that in the control group,while the plasma miR-143-3p level was lower(P<0.05).The plasma LncRNA PVT1 levels decreased sequentially in the severe activity,moderate activity,mild activity,and dis-ease stable groups,while the plasma miR-143-3p levels increased sequentially(P<0.05).The proportion of patients positive for human leukocyte antigen-DR4(HLA-DR4),DAS28,and plasma LncRNA PVT1 expression level were higher in the poor prognosis group than in the good prognosis group,while the plasma miR-143-3p level was lower(P<0.05).Plasma LncRNA PVT1,miR-143-3p expression,HLA-DR4 positivity,and DAS28 were factors influencing the prognosis of RA patients(P<0.05).LncRNA PVT1 and miR-143-3p had targeted binding sites,and there was a negative correlation between them(P<0.05).The area under the curve(AUC)for the combined prediction of plasma LncRNA PVT1 and miR-143-3p for prognosis of RA patients was 0.914,which was superior to the individual diagnosis of LncRNA PVT1 or miR-143-3p(Z=2.159,P=0.031;Z=2.108,P=0.035).The sensitivity and specificity of the combined diagnosis were 95.12%and 78.41%,respectively.Conclusion The plasma LncRNA PVT1 level gradually increases,while the plasma miR-143-3p level gradually decreases with increasing RA disease activity.The combined detection of the two biomarkers has high predictive value for the prognosis of RA patients.

rheumatoid arthritislong non-coding RNA plasmacytoma variant translocation 1microRNA-143-3pdisease activityprognosis

崔欣、闫晓雯、孙晓、付妍妍、陶然

展开 >

河北省沧州市中心医院风湿免疫科,河北沧州,061000

类风湿关节炎 长链非编码RNA浆细胞瘤变异易位基因1 微小RNA-143-3p 疾病活动度 预后

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(24)